Polyneuropathy

Fingolimod Does Not Slow Worsening of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Fingolimod Does Not Slow Worsening of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

By

The trial was ended for futility when a total of 44 worsening events had occurred in the cohort.

First-in-Class Therapy Approved for Polyneuropathy Caused by hATTR

First-in-Class Therapy Approved for Polyneuropathy Caused by hATTR

By

The mechanism of siRNAs consists of silencing a portion of RNA involved in causing the disease.

Patisiran is effective in treatment of hereditary transthyretin amyloidosis.

Patisiran, an RNA interference agent, improved neuropathy symptoms and motor function in patients with hereditary transthyretin amyloidosis after 18 months of use.

Electrophysiologic Features Specific to Transthyretin Familial Amyloid Polyneuropathies

Electrophysiologic Features Specific to Transthyretin Familial Amyloid Polyneuropathies

By

Reduced amplitude of the ulnar motor nerve and the sural nerve action potentials may be specific to transthyretin familial amyloid polyneuropathies, allowing us to distinguish this disorder from other demyelinating polyneuropathies.

CAPPRI Scale is Feasible for Assessing Health-Related Quality of Life in Diabetic Distal Sensorimotor Polyneuropathy

CAPPRI Scale is Feasible for Assessing Health-Related Quality of Life in Diabetic Distal Sensorimotor Polyneuropathy

By

Investigators evaluated the performance of the CAPPRI in assessing health-related quality-of-life outcomes in patients with diabetic distal sensorimotor polyneuropathy.

Hizentra Approved for Chronic Inflammatory Demyelinating Polyneuropathy

Hizentra Approved for Chronic Inflammatory Demyelinating Polyneuropathy

By

The PATH study demonstrated that the percentage of patients experiencing CIDP relapse or withdrawal for any other reason during SCIg treatment was significantly lower with Hizentra.

FDA Approves Demyelinating Polyneuropathy Treatment

FDA Approves Demyelinating Polyneuropathy Treatment

By

Privigen is a ready-to-use liquid intravenous immune globulin product stabilized with proline.

Long-Term Opioid Therapy Tied to Worse Outcomes in Polyneuropathy

Long-Term Opioid Therapy Tied to Worse Outcomes in Polyneuropathy

By

Most prescriptions for long-term opioid therapy were written by internal or family medicine physicians.

Sign Up for Free e-newsletters



CME Focus